Service Agreement for Revvity SciClone G3 NGSx and Zephyr

The Centers for Disease Control and Prevention intends to award a sole source purchase order to Revvity Health Sciences, Inc. for a gold plan preventative maintenance agreement on a SciClone G3 NGSx Workstation, Zephyr G3 NGS Workstation, and another SciClone G3 NGSx Workstation. The contractor will provide routine maintenance and emergency repairs for these specialized next-generation sequencing laboratory instruments over a two-year period to support the agency's standard laboratory operations and emergency response efforts. The CDC has determined that Revvity is the only authorized source that can provide certified engineers and proprietary parts to ensure consistent operation of these systems. The contracting office has certified the sole source justification as accurate and complete.

This proposed contract has no set-aside designation. As Revvity is the only authorized source for maintenance and repairs on these specific systems, the CDC intends to solicit only from Revvity under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1). The notice provides that any responses should be submitted to the contract specialist by February 7, 2024, and that a decision not to compete the proposed contract is within the government's discretion.